Cancer-Targeted Selenium Nanoparticles

  • ChemPubSoc Europe Logo
  • Author: Andrei Dragan
  • Published Date: 17 October 2017
  • Source / Publisher: Chemistry – An Asian Journal/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA
thumbnail image: Cancer-Targeted Selenium Nanoparticles

Cancer radiotherapy with 125I seeds has shown long-term higher efficacy and lower side effects than traditional X-ray radiotherapy owing to low dosage and continuous radiation. However, it is still limited by radioresistance in clinical applications. Therefore, the design and synthesis of sensitizers that could enhance the sensitivity of cancer cells to 125I seeds is of great importance.

Selenium nanoparticles (SeNPs) are of interest due to their high potential for cancer chemotherapy and as carriers of anticancer drugs. Tianfeng Chen, Jinan University, China, and colleagues have designed and synthesized cancer-targeted SeNPs and found that they have synergetic effects in combination with 125I seeds. The combination inhibits cancer-cell growth and colony formation through the induction of cell apoptosis and cell-cycle arrest. The combined treatment effectively activates intracellular reactive oxygen species (ROS) overproduction and prevents the self-repair of cancer cells.

The combination of SeNPs with 125I seeds could be useful as a safe and effective strategy for next-generation cancer chemo-radiotherapy in clinical applications.


Article Views: 1585

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH